The Scientist

» innovation, disease/medicine and culture

Most Recent

image: How Castor Oil Stimulates Labor

How Castor Oil Stimulates Labor

By | May 21, 2012

Researchers flag the EP3 prostaglandin receptor as a key player in castor oil’s laxative and labor-inducing effects.

0 Comments

image: HIV Prevention Debate

HIV Prevention Debate

By | May 21, 2012

The suggested approval of a widely used antiretroviral drug to prevent HIV transmission in uninfected people sparks a debate about the possible dangers of such a move.

1 Comment

image: Misconduct on the Rise

Misconduct on the Rise

By | May 21, 2012

Retractions of scientific studies due to plagiarism, falsification, and other instances of researchers behaving badly have skyrocketed in the past decade.

8 Comments

image: Gene Therapy for Brain Disease

Gene Therapy for Brain Disease

By | May 16, 2012

Delivering a missing enzyme to the brains of paralyzed children with a rare, life-threatening neurological disease restores movement and builds muscle mass.

0 Comments

image: How Much Do You Make?

How Much Do You Make?

By | May 16, 2012

Fill out our annual Salary Survey to help us calculate the most current salary data for life scientists.

0 Comments

image: Breastfeeding Toddlers Okay

Breastfeeding Toddlers Okay

By | May 16, 2012

A provocative Time cover featuring a breastfeeding 3-year-old sparks anger from doctors.

3 Comments

image: Vulva Cave Art

Vulva Cave Art

By | May 15, 2012

Engravings of female genitalia in a cave in southern France may be the oldest cave art yet discovered.

8 Comments

image: Does Education Boost Health?

Does Education Boost Health?

By | May 15, 2012

An examination of Swedish health and educational records suggests that more schooling results in healthier adults.

2 Comments

image: Bionic Eye Sees the Light

Bionic Eye Sees the Light

By | May 15, 2012

A light-powered retinal implant restores vision in rats.

0 Comments

image: Opinion: Misleading Drug Trials

Opinion: Misleading Drug Trials

By | May 14, 2012

Amgen’s incomplete report on an early major trial of epoetin misled the medical community about the anemia drug’s risks and benefits—and helped make Amgen rich.

23 Comments

Popular Now

  1. How Plants Evolved Different Ways to Make Caffeine
  2. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  3. Sequencing Reveals Genomic Diversity of the Human Brain
  4. Reviewing Results-Free Manuscripts
    The Nutshell Reviewing Results-Free Manuscripts

    An open-access journal is trialing a peer-review process in which reviewers do not have access to the results or discussion sections of submitted papers.

RayBiotech